121 related articles for article (PubMed ID: 12908548)
1. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.
Esteller M
Adv Exp Med Biol; 2003; 532():39-49. PubMed ID: 12908548
[TBL] [Abstract][Full Text] [Related]
2. Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.
Toyota M; Suzuki H; Yamashita T; Hirata K; Imai K; Tokino T; Shinomura Y
Cancer Sci; 2009 May; 100(5):787-91. PubMed ID: 19236379
[TBL] [Abstract][Full Text] [Related]
3. Dissecting DNA hypermethylation in cancer.
Estécio MR; Issa JP
FEBS Lett; 2011 Jul; 585(13):2078-86. PubMed ID: 21146531
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic gene silencing in cancer: the DNA hypermethylome.
Esteller M
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R50-9. PubMed ID: 17613547
[TBL] [Abstract][Full Text] [Related]
5. Role of Epigenetics for the Efficacy of Cisplatin.
Lumpp T; Stößer S; Fischer F; Hartwig A; Köberle B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256203
[TBL] [Abstract][Full Text] [Related]
6. Study of
Biswas P; Bibi S; Yousafi Q; Mehmood A; Saleem S; Ihsan A; Dey D; Hasan Zilani MN; Hasan MN; Saleem R; Awaji AA; Fahmy UA; Abdel-Daim MM
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049742
[TBL] [Abstract][Full Text] [Related]
7. Expression and Significance of N-myc downstream regulated gene 2 in the process of Esophageal Squamous Cell Carcinogenesis.
Feng RB; Zhou QZ; Cheng R; Li P; Zhu ST; Min L; Zhang ST
Bioengineered; 2022 Feb; 13(2):3275-3283. PubMed ID: 35048779
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
[TBL] [Abstract][Full Text] [Related]
9. A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.
Li Y; Ren Y; Wang Y; Tan Y; Wang Q; Cai J; Zhou J; Yang C; Zhao K; Yi K; Jin W; Wang L; Liu M; Yang J; Li M; Kang C
Theranostics; 2019; 9(16):4608-4623. PubMed ID: 31367244
[TBL] [Abstract][Full Text] [Related]
10. Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome.
Mahmoud AM; Ali MM
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871166
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in assisted reproductive technology.
Katagiri Y; Shibui Y; Nagao K; Miura K; Morita M
Reprod Med Biol; 2007 Jun; 6(2):69-75. PubMed ID: 29662404
[TBL] [Abstract][Full Text] [Related]
12. Diminished expression of
Bhat AA; Wani HA; Waza AA; Malik RA; Masood A; Jeelani S; Kadla S; Majid S
J Gastrointest Oncol; 2016 Dec; 7(6):989-995. PubMed ID: 28078123
[TBL] [Abstract][Full Text] [Related]
13. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
[TBL] [Abstract][Full Text] [Related]
14. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
15. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma.
Lai ZL; Tsou YA; Fan SR; Tsai MH; Chen HL; Chang NW; Cheng JC; Chen CM
Biomed Res Int; 2014; 2014():378358. PubMed ID: 25197641
[TBL] [Abstract][Full Text] [Related]
16. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
Hu CY; Mohtat D; Yu Y; Ko YA; Shenoy N; Bhattacharya S; Izquierdo MC; Park AS; Giricz O; Vallumsetla N; Gundabolu K; Ware K; Bhagat TD; Suzuki M; Pullman J; Liu XS; Greally JM; Susztak K; Verma A
Clin Cancer Res; 2014 Aug; 20(16):4349-60. PubMed ID: 24916699
[TBL] [Abstract][Full Text] [Related]
17. p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review.
Al-Kaabi A; van Bockel LW; Pothen AJ; Willems SM
Dis Markers; 2014; 2014():260549. PubMed ID: 24803719
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells.
Ceccarelli V; Nocentini G; Billi M; Racanicchi S; Riccardi C; Roberti R; Grignani F; Binaglia L; Vecchini A
PLoS One; 2014; 9(1):e85025. PubMed ID: 24454781
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.
Fatemi M; Paul TA; Brodeur GM; Shokrani B; Brim H; Ashktorab H
Cancer; 2014 Jan; 120(2):172-80. PubMed ID: 24243398
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.
Jung EJ; Kim IS; Lee EY; Kang JE; Lee SM; Kim DC; Kim JY; Park ST
Ann Lab Med; 2013 Nov; 33(6):431-40. PubMed ID: 24205493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
